Usa Financial Portformulas Corp Innoviva, Inc. Transaction History

Usa Financial Portformulas Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 31, 2018	SELL	$13.63 - $15.7 $608,811 - $701,271	-44,667 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$13.44 - $17.59 $927 - $1,213	-69 Reduced 0.15%	44,667 $745,000
Q1 2018 Apr 03, 2018	BUY	$13.8 - $16.99 $617,356 - $760,064	44,736 New	44,736 $746,000
Q4 2017 Feb 13, 2018	SELL	$11.73 - $14.75 $785,616 - $987,881	-66,975 Closed	0 $0
Q3 2017 Nov 02, 2017	SELL	$12.06 - $14.12 $4,124 - $4,829	-342 Reduced 0.51%	66,975 $946,000
Q3 2017 Oct 11, 2017	BUY	$12.06 - $14.12 $811,843 - $950,516	67,317	67,317 $951,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.